PAVmed Successfully Completes Clinical Safety Study Procedures for CarpX™ 510(k) Re-submission All 20 patients underwent successful CarpX procedures while passing primary effectiveness endpoint, with all follow-up patients to date passing primary safety endpoint NEW YORK, Aug. 15, 2019 ...